Just - Evotec Biologics
Catherine Liloia is a seasoned professional in the biotechnology and pharmaceutical industries, currently serving as Vice President of Global Quality Control at Just - Evotec Biologics since April 2024. Prior to this role, Catherine was Senior Director of Cell and Microbiology at PPD from July 2017 to April 2024. Earlier experience includes serving as Senior Manager for QC Biological Testing at Regeneron Pharmaceuticals, Inc. from June 2012 to July 2017, and holding various positions at Amgen from July 2001 to June 2012, including Senior Associate Scientist in Analytical Sciences, QAL Senior Associate in Cell Immunobiology, and Cell Culture Technician. Catherine earned a Master of Science in Biotechnology from the University of Rhode Island and a Bachelor of Science in Biology from Penn State University.
This person is not in any teams
This person is not in any offices
Just - Evotec Biologics
1 followers
Just – Evotec Biologics, wholly owned by Evotec SE, is a first-to-industry biologics platform that leverages AI/ML technologies and world-leading molecular design, cell line development, process intensification and continuous manufacturing strategies to advance biotherapeutics from discovery through clinical stages to commercial launch. The Just – Evotec Biologics team combines deep industry experience in the fields of data, protein, process, and manufacturing sciences including automation with highly integrated and flexible capabilities to break through the scientific and economic barriers associated with the development of protein therapeutics. Our focus is to accelerate and expand access to biotherapeutics through scientific and technological innovation for our proprietary projects and on behalf of our partners. Learn more at www.just-evotecbiologics.com